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Abstract For long the medical literature has shown that
patients do not always receive appropriate care, including
pharmacotherapeutic treatment. To achieve improved
patient care, a number of physician-oriented interventions
are being delivered internationally in an attempt to
implement evidence based medicine in routine daily
practice of medical practitioners. The pharmacy profession
has taken an active role in the delivery of intervention
strategies aimed at promoting evidence based prescribing
and improved quality and safety of medicine use. However,
the medical literature also supports the notion that valid
clinical care recommendations do not always have the
desired impact on physician behaviour. We argue that the
well-established theory of psychological reactance might at
least partially explain instances when physicians do not act
upon such recommendations. Reactance theory suggests
that when recommended to take a certain action, a moti-
vational state compels us to react in a way that afﬁrms our
freedom to choose. Often we choose to do the opposite of
what the recommendation is proposing that we do or we
just become entrenched in our initial position. The basic
concepts of psychological reactance are universal and
likely to be applicable to the provision of recommendations
to physicians. Making recommendations regarding clinical
care, including pharmacotherapy, may carry with it implied
threats, as it can be perceived as an attempt to restrict one’s
freedom of choice potentially generating reactance and
efforts to avoid them. By identifying and taking into
account factors likely to promote reactance, physician-
oriented interventions could become more effective.
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It is well known that the use of medicines often results in
avoidable complications or adverse events. In the United
States a study showed that approximately 60% of iatro-
genically related admissions to intensive care units were
drug related and 75% were preventable [1]. In Australia,
adverse medicine events are responsible for 1.6% of all
hospital admissions [2].
To achieve improved quality and safety of medicine use,
a number of physician-oriented interventions are being
delivered internationally in an attempt to improve evidence
based prescribing in routine daily practice of medical
practitioners—e.g., distribution of educational materials,
decision support systems, outreach visits, medication
reviews, etc.
The pharmacy profession has taken an active role in the
delivery of intervention strategies related to pharmaco-
therapy. For example, in medication review programmes,
pharmacists interview patients, conduct assessments of
information gathered on patients’ use of medicines and
prepare reports for physicians, which may contain phar-
macotherapeutic recommendations [3]. Pharmacists also
are typically involved in educational outreach programmes.
In such programmes it is common for pharmacists to take
up the role of educator, visiting physicians in their ofﬁce to
provide educational interventions on speciﬁc pharmaco-
therapeutic topics. As pharmacists and physicians share
A. C. de Almeida Neto (&)  T. F. Chen




Pharm World Sci (2008) 30:3–8
DOI 10.1007/s11096-007-9143-xexpertise in pharmacotherapy, their involvement in inter-
vention strategies aimed at promoting quality and safety of
medicine use makes sense. Indeed, the literature has
reported positive results on patient health outcomes arising
from such interventions [4, 5].
However, despite the delivery of interventions designed
to foster quality and safety of medicine use, the literature
provides support for the notion that, at times, despite
physicians agreeing to the value of evidence based clinical
recommendations, intervention strategies do not always
have an impact on physician behaviour. For example, in a
study in which both physicians and community pharmacists
had negotiated actions based on medication reviews, the
researchers were only able to document a rate of imple-
mentation of 42% of the proposed actions [6]. These
ﬁndings are supported by our own experience working with
community pharmacists involved in medication manage-
ment programmes in Australia. Some of these pharmacists
report that sometimes their recommendations have the
desired impact on physician choice of pharmacotherapy,
but at times they have no impact at all and in some
instances they even cause physicians to respond negatively.
As expected, failure to change physician behaviour is
not restricted to the prescribing area. Indeed, non-compli-
ance to evidence based recommendation is a consistent
ﬁnding in clinical care research [7]. For example, Grol and
Grimshaw [7] note that hospital-acquired infections affect
one in every 11 patients with 13% mortality rate and that
15–30% of infections are considered to be preventable by
handwashing [8]. Still, compliance with handwashing by
health care providers, in particular medical practitioners, is
known to be poor [7]. Indeed, with surprising frequency,
and to the considerable dismay of interventionists, physi-
cian-oriented interventions often fail to improve hand-
washing behaviour [7, 9]. Without a doubt while there are
certainly circumstances that may lead physicians to justi-
ﬁably question clinical care recommendations, in general
non-compliance to evidence based recommendations
proves costly to patients and society alike.
Currently, there is a lack of theoretical framework for
understanding instances when valid recommendations do
not lead to the desired impact on physician behaviour. The
key question is: What are the barriers that impede physi-
cian acceptance of valid recommendations? We argue that
the theory of psychological reactance [10] might at least
partially explain instances when evidence based recom-
mendations fail to impact on physician behaviour.
Psychological reactance
Psychological reactance is a tendency to resist perceived
attempts by others to control the individual’s behaviour
[10]. Most of us like to perceive ourselves as being in
control; we value our sense of freedom and autonomy and
like to project an image of being in control [11]. In general,
when we perceive that our freedom of choice is being
restricted by the action of others, we react in a way that
afﬁrms our ability to choose. Often we choose to do the
opposite of what the recommendation is proposing that we
do or we just become entrenched in our initial position. This
phenomenon is called psychological reactance [10]. Reac-
tance is directed towards reattaining the restricted freedom;
a motivational state compels us to reassert that freedom
[10]. In many circumstances, reactance results in an
increase in the attractiveness of the constrained behaviour
and an increased sense of conﬁdence in the ultimate deci-
sion made [10]. Particular noteworthy is the ﬁnding that
reactance appears to be a biological tendency, an inherent
human characteristic. At the very least, it can be said that
reactance manifests itself at a very young age [12].
For the last four decades the theory of psychological
reactance has been widely tested and applied with reac-
tance being widely recognised as a powerful determinant of
behaviour. To date, studies across a vast array of behav-
iours have consistently demonstrated that recommending
that individuals take a certain course of action often pro-
duces the opposite effect, consistent with this tendency to
resist perceived attempts by others to restrict freedom of
choice. For example: in the marketing area research indi-
cates that expert recommendations are desirable as long as
they are consistent with the choice tendency of individuals.
When expert recommendations contradict the consumer’s
choice tendencies, a reactant state is activated on the part of
the decision maker leading to a behavioral ‘‘backlash’’ that
results not only in consumers ignoring the recommenda-
tions but in intentionally contradicting them [13]. Not only
there is an increase in choice of the non-recommended
option, but also a signiﬁcant increase in conﬁdence in the
non-recommended option [13].
In the healthcare literature, psychological reactance has
been primarily used to explain patient non-compliance, i.e.,
why some patients refuse to cooperate with medical treat-
ment [14, 15]. Fogarty and Young [15] conducted research
that indicates that individual variability in compliance to a
medication regimen is related to individual variability in
reactance as a personality trait [15]. Psychological reac-
tance has also for long been observed in the natural setting
in response to perceived attempts to restrict one’s freedom
of choice. A classic example of psychological reactance in
the everyday life took place when a city in the United
States banned the possession and use of laundry detergents
containing phosphates for environmental reasons. It was
found that residents stockpiled an enormous quantity of
detergents containing phosphates before the ban went into
effect. Others organised carpools to neighbouring counties
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result of the ban, the perceived value of the prohibited
products was increased; compared with residents in
neighbouring counties, who were free to choose whatever
detergent they liked, residents subjected to the ban rated
phosphate detergents as gentler, easier to pour, better
whiteners and stain removers, and more effective in cold
water. It is noted that phosphates have no impact whatso-
ever on the cleaning effectiveness of detergents.
Psychological reactance and physician-oriented
interventions
The long history of successful support for reactance theory
in diverse settings and areas of behaviour may also have
implications for physician-oriented interventions in which
evidence based clinical recommendations are provided, as
health care providers may not be immune to the phenom-
enon of psychological reactance. It is true that the basic
concepts of psychological reactance are universal and
likely also to be applicable to the provision of evidence
based clinical recommendations to physicians.
In the context of physician-oriented interventions, the
theory and research on psychological reactance would
predict that at times when opposing recommendations are
provided, physicians’ perceptions of threats to their free-
dom to select an appropriate course of action could produce
the opposite reaction leading them to become more likely
to ignore the recommendation or to choose the non-rec-
ommended option. This would be the case even in cir-
cumstances where physicians may agree, in essence, to the
value of the recommendation.
...to the extent that it is perceived by the individual
that the communicator is trying to make him change,
his freedom to decide for himself will be threatened
and he will experience reactance... Information and
arguments can be quite helpful to the individual and
may result in positive inﬂuence, but the perception
that the communicator is attempting to inﬂuence will
tend to be seen as a threat to one’s freedom to decide
for oneself ([10], p. 94 cited in [14]).
Indeed, making recommendations regarding clinical care,
including pharmacotherapy, may carry with it implied
threats, as it can be perceived as an attempt to restrict one’s
freedom of choice generating reactance and efforts to avoid
them. Furthermore, the inherent ‘‘veto’’ power that physi-
cians have over the treatment regimen may facilitate
manifestation of reactant-style responses making non-
compliance to evidence based recommendations more
likely to occur.
It is also important to recognise that even in
circumstances where physicians agree to participate in
interventions, they may not necessarily expect their prac-
tice to be challenged. For example, there are several pos-
sible reasons for a physicians agreeing to a medication
review. In some cases, physicians may wish to monitor the
individual patient’s self-medication habits or they may be
concerned about possible patient non-compliance with the
medication regimen.
It is also true that physicians have for long subscribed
to a body of ethical rules created above all for the
beneﬁt of the patient [18]. Professional behaviour of
medical practitioners is guided by these ethical rules,
which dictate what is morally approved and disapproved
conduct specifying what ought to be done [18]. It is
reasonable to expect medical ethics to have a consider-
able impact on physician decision-making in situations
that involve potential harm to the patient. For example,
the use of a non-steroidal anti-inﬂammatory drug
(NSAID) in a patient taking the anticoagulant warfarin
puts the patient at an increased risk of bleeding. In such
situations, which involve potential harm to the patient,
recommendations arising from intervention strategies
most certainly will be recognised by the physician as an
injunctive professional norm (a norm of ‘‘what ought to
be done’’) and most certainly will be implemented.
However, it is possible that providing physicians with
valid opposing clinical care recommendations that do not
involve potential harm to the patient may at times be
counterproductive. For example, in a patient with low
gastrointestinal and cardiovascular risk, recommendation
to use a non-selective NSAID if the patient is responding
well to a COX-2 selective NSAID, may be perceived as
an unwarranted attempt to restrict one’s action, increas-
ing the likelihood of a reactant-style response.
Although no study appears to have speciﬁcally
addressed reactance from a health care providers’ per-
spective, a recent qualitative study has provided some
indication that reactance might play a role in physician
decision-making in response to pharmacotherapeutic rec-
ommendations [19]. This study investigated determinants
of successful collaboration between community pharma-
cists and physicians in medication review. Participating
pharmacists discussed the need to be diplomatic in their
recommendations, as they believed physicians’ misper-
ception that they were ‘‘telling them what to do’’ could
induce dismissal of their recommendations.
Possible determinants of reactance
It is possible that reactant responses may be more likely to
occur in situations where the physician has not requested
the information/recommendation. Experiments outside the
medicines area have demonstrated that unsolicited infor-
mation can evoke psychological reactance even when
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information beyond what the decision maker knows [20].
Interestingly enough, in situations where the recommended
action went contrary to the individual’s choice tendency,
this reactance to unsolicited information was signiﬁcantly
more likely to occur when recommendations came from a
source perceived to be an expert [20]. The authors suggest
that unsolicited recommendations may be perceived as
more of a threat or an intrusion when they come from
credible sources. It is noted that although unsolicited
information is typically provided to physicians through
written materials and computerised decision support sys-
tems, in some programmes medicines use review can be
initiated by the pharmacist and report sent to the patient’s
physician in an unsolicited fashion [21].
It is also possible that the perception that the particular
interventionist is directing recommendations speciﬁcally to
the particular physician, as opposed to the treatment of the
patient’s condition in general, also could make reactance
more likely to occur. Brehm [10] demonstrated that reac-
tant responses are more likely to occur when individuals
perceive the constraint as being speciﬁcally directed at
them as opposed to when it is perceived to be impersonal
[10]. If indeed, this is found also to apply to physician-
oriented interventions, it may have implications for how
pharmacists and other health care professionals provide
recommendations to physicians.
Sense of medical professionalism might also be
implicated in reactant responses. We do value our sense
of freedom and autonomy and we like to project an
image of being in control [11]. Indeed, physicians are
trained to make sound decisions with regard to treatment
regimen and it is reasonable to expect them to believe
that they are in control and have the knowledge and
skills required to make the best possible decisions. The
acceptance of a contrary recommendation to what is
being used to treat the patient’s illness could undermine
the physician’s own sense of competence, reducing the
cognitive basis of professionalism. On the other hand,
dismissal of the recommended option could have the
opposite effect reinforcing physician’s ability to choose
the most appropriate treatment.
We also know that once aroused, reactance may
heighten individual’s sensitisation to additional threats to
freedom of control [22]. It is also reasonable to believe that
at a time when governments are encouraging greater
involvement of allied healthcare professionals in patient
care, issues related to professional territoriality may sen-
sitise physicians to reactance in response to recommenda-
tions from allied healthcare professionals, including the
pharmacist. Although the literature reports positive medical
profession’s attitudes to pharmacists and their clinical role,
some sentiments of encroachment are supported by studies
that found that not all physicians view favourably greater
involvement of pharmacists in patient care [23–25]. Thus,
the physician-pharmacist interaction in the intervention
process could be burdened with social and personal pres-
sures, which can increase the possibility of a reactant re-
sponse. Indeed, psychological reactance may offer a
theoretical framework that could enhance our understand-
ing of the, at times, difﬁcult relationship between phar-
macists and physicians.
It is also possible that the nature of the physician rela-
tionship with the allied healthcare professional is also a
determinant of reactance. For example, it has been argued
that the most successful pharmacist interventions have
been those in which the pharmacist works in close liaison
with the physician [26]. Indeed, in the United States much
of the evidence supporting pharmacist involvement in
collaborative drug therapy management is derived from the
ambulatory care setting [27] where routine contact with
physicians may allow for the development of the trusting
relationship needed for interprofessional collaboration
[28].
Finally, another factor that may determine reactant
responses to recommendations include individual differ-
ences, as some people are more likely to have a reactant
response in general to any perceived constraint [29].
Individual variations in susceptibility to reactance can
explain why identical situations may lead to markedly
different perceptions of threat and magnitudes of reactant
responses in different persons. Indeed, scales developed
to measure reactance as a trait demonstrate that indi-
vidual reactance levels lie along a continuum from very
low to very high [29]. Naturally, in the context of
physician-oriented interventions, the nature and intensity
of the reactant response is also likely to be a function of
how much the particular physician values his/her free-
dom to select the treatment option him/herself. Again, a
recent qualitative study provides some support to the
notion that some physicians are more prone to psycho-
logical reactance than others [19]. In this study, per-
sonality of medical practitioners was discussed as a
factor inﬂuencing the outcome of medication review.
Participating pharmacists distinguished between physi-
cians who they thought were amenable to discussing
their prescribing decisions and those who were not.
These results indicate that interventionists do assess the
reactance potential of the individual physician although it
is unlikely that they label the assessment as such. It is
noteworthy that when interventionists sense reactance in
their interaction with the physician, they may be faced
with a difﬁcult dilemma, as they are aware of the pos-
sibility that the provision of evidence based clinical
recommendation may trigger the opposite response. What
can the interventionist do in such situation?
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A phenomenon like psychological reactance, which is
likely to impede the desired outcome of physician-oriented
interventions, needs to be adequately addressed when
training healthcare professionals to deliver such interven-
tions. We must be mindful that the process of delivering
physician-oriented interventions can be difﬁcult as psy-
chological reactance is not a reasonable or rational
response; it can cause people to become highly emotional
and motivated to defend their behaviour.
Prior research on reactance suggests that individuals’
ability to exercise some choice (freedom) in relation to
recommendations may impact on compliance to the advice
provided. That is, maximising the individual’s perception
of free choice can minimise reactance [22]. It is possible
that the degree to which the physician is incorporated in the
selection of evidence based clinical care practices may
affect the extent to which the intervention will induce
reactance. Indeed, it is possible that intervention strategies
which give physicians the impression they have little or no
say on their own clinical practices will be less likely to be
effective, as they are perceived as more threatening,
compared to those where physicians perceive themselves
as exercising some choice.
We are now training pharmacists on how to deal with
psychological reaction in the context of medication review.
We also expect such training to enhance commitment to
the pharmacy lead intervention from the interventionist’s
perspective, as after being equipped with tools for dealing
with reactance, pharmacists may experience a greater sense
of self-efﬁcacy in dealing with all types of physicians,
including those who are highly reactant. In addition,
awareness of reactant responses and its causes may assist
pharmacists and other healthcare professionals in altering
their emotional response to reactant behaviour avoiding a
decreased sense of self-efﬁcacy.
Concluding remarks
The current paper addressed an intrinsic human charac-
teristic, psychological reactance, as a factor that may
inﬂuence the outcome of physician-oriented intervention
strategies, including those typically delivered by pharma-
cists. Although psychological reactance has not been tested
from a healthcare provider’s perspective, there is enough
research to suggest the basic cognitive process represented
is universal and also valid in the context of clinical care
recommendations in the healthcare setting. Indeed, reac-
tance theory ﬁts well as it offers some explanation of why
at times valid recommendations fail to have the desired
impact on physician behaviour.
It is possible that as human beings, even healthcare
professionals are subjected to the same human emotions
and weaknesses as humans in general. However, a role for
reactance in clinical care recommendations needs to be
investigated empirically. If this role is established, factors
likely to increase the potential for reactance may need to be
taken into account when implementing intervention strat-
egies that attempt to inﬂuence physician behaviour.
It also is acknowledged that physician non-compliance
to valid recommendations is more likely to be a complex,
multi-faceted phenomenon. Physicians may not adhere to
evidence based recommendations for a number of reasons
unique to the individual patient, and the circumstance. It is
most likely that reactance, although a powerful determinant
of behaviour in general, is only one of the many factors that
inﬂuence decision-making in relation to clinical care/
pharmacotherapeutic recommendations.
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